SCHEMBL21062093

SCHEMBL21062093

CCOn1c(=O)ccn(CC(=O)O)c1=O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ AKR1B10 O60218 1/20 0.38
▸ AKR1B1 P15121 1/20 0.38
▸ LMNA P02545 3/20 0.36
▸ PKM P14618 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ APEX1 P27695 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ HTT P42858 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ ADORA2B P29275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7567713 0.85 ALDH1A1 (0.44) KMT2AALDH1A1MAPTKDM4EPOLB
SCHEMBL11711947 0.76 KDM4E (0.47) KMT2AALDH1A1MAPTKDM4EPOLB
SCHEMBL27619838 0.73 KMT2A (0.43) KMT2AALDH1A1MAPTKDM4EPOLB
SCHEMBL3582727 0.70 GSK3A (0.50) KMT2AALDH1A1MAPTKDM4EPOLB
SCHEMBL3581778 0.70 ALDH1A1 (0.43) KMT2AALDH1A1MAPTKDM4EPOLB
SCHEMBL6280747 0.69 KDM4E (0.45) KMT2AALDH1A1MAPTKDM4EPOLB
SCHEMBL16888062 0.67 ALDH1A1 (0.41) KMT2AALDH1A1MAPTKDM4EPOLB
SCHEMBL3590708 0.66 ALDH1A1 (0.43) KMT2AALDH1A1MAPTKDM4EPOLB
SCHEMBL4591705 0.66 KDM4E (0.56) KMT2AALDH1A1MAPTKDM4EPOLB
SCHEMBL23212090 0.66 PKM (0.34) KMT2AALDH1A1KDM4ELMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3810094-A1 TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A JAK OR OTHER KINASE INHIBITOR Progenity, Inc. (US) 2021-04-28 — — EP disclosed
EP-3810095-A1 TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A TNF INHIBITOR Progenity, Inc. (US) 2021-04-28 — — EP disclosed
WO-2021067313-A1 EUKARYOTIC SEMI-SYNTHETIC ORGANISMS THE SCRIPPS RESEARCH INSTITUTE (US) 2021-04-08 — — WO disclosed
EP-3723801-A1 TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A S1P MODULATOR Progenity, Inc. (US) 2020-10-21 — — EP disclosed
WO-2019118778-A1 TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A S1P MODULATOR PROGENITY, INC. (US) 2019-06-20 — — WO disclosed
Send feedback